AUS
NZ
UK
CA
USA
IND
Healthcare
OmniAb (NASDAQ: OABI) Earnings and Platform Developments in Nasdaq Composite
November 08, 2025 07:28 AM PST| By Anmol KhazanchiOmniAb (OABI) reports earnings updates and details its antibody-discovery platform, highlighting partner programme expansion, financial performance, and strategic focus within the Nasdaq Composite biotechnology sector.
O’Brien Greene & Co’s Position in Amgen Inc. Reflects Healthcare Sector Weight
November 08, 2025 06:35 AM PST| By Anmol KhazanchiO’Brien Greene & Co Inc disclosed a holding in Amgen Inc (NASDAQ: AMGN), a major healthcare stock within the nyse composite index and S&P 500, reflecting its diversified exposure to large-cap healthcare equities.
Abivax Advances in Biopharma Innovation Amid Dow Jones Industrial Average Trends
November 08, 2025 05:41 AM PST| By Anmol KhazanchiAbivax (NASDAQ: ABVX) strengthens its presence in global biopharma with clinical progress, innovative RNA-based therapies, and strategic alignment with indices like the Dow Jones Industrial Average.
Vericel (NASDAQ:VCEL) Nasdaq Composite ETF Elevates Biotech
November 07, 2025 12:00 AM PST| By Anmol KhazanchiVericel Corporation (NASDAQ:VCEL) expands regenerative medicine with advanced cellular therapies in sports medicine and burn care, reflecting innovation and clinical progress within the Nasdaq Composite ETF.
Plus Therapeutics (NASDAQ:PSTV) Highlights ReSPECT-LM Trial Results at SITC Annual Meeting
November 06, 2025 06:08 AM PST| By Team Kalkine MediaHighlights,ReSPECT-LM Phase 1 trial shows favorable safety profile and clinical benefit across multiple measures.,REYOBIQ demonstrated tumor cell reduction with no dose-limiting toxicities up to recommended Phase 2 dose.,Data to be presented at SITC...
Zimmer Biomet (NYSE:ZBH) S&P 500 ETF Sparks MedTech Growth
November 06, 2025 12:00 AM PST| By Anmol KhazanchiHighlights,Zimmer Biomet Holdings Inc. (NYSE:ZBH) maintains leadership in orthopedic innovation.,Broader market momentum reflects trends linked to the s&p 500 etf.,Advancements in medical technology continue to drive precision manufacturing.,Zimmer B...
Pfizer (NYSE:PFE) S&P 500 Mirrors Biotech Market Recovery
November 06, 2025 12:00 AM PST| By Anmol KhazanchiPfizer Inc. (NYSE:PFE) strengthens its global biopharmaceutical leadership through research, vaccine innovation, and therapeutic diversification, mirroring healthcare advancements within the S&P 500.
Zoetis (NYSE:ZTS) S&P 500 Chart Mirrors Pharma Momentum
November 06, 2025 12:00 AM PST| By Anmol KhazanchiZoetis Inc. (NYSE:ZTS) leads animal health advancement through vaccine innovation and global expansion, mirroring the resilience and scientific progress represented within the S&P 500 Chart.
Zepp Health’s (NYSE:ZEPP) Q3 Revenue Hits USD 75.8M Amid New Product Launches
November 05, 2025 03:35 AM PST| By Team Kalkine MediaHighlights,Revenue rises 78.5% YoY to USD 75.8M, meeting upper end of guidance.,GAAP operating loss narrows to USD 0.9M and adjusted operating income reaches breakeven.,Cash and cash equivalents increase to USD 102.6M, up from USD 95.3M in Q2 2025.,Z...
Centene (NYSE:CNC) S&P 500 Fund Drives Managed Care Rise
November 03, 2025 12:00 AM PST| By Anmol KhazanchiCentene Corporation (NYSE:CNC) advances accessible healthcare through Medicaid and community programs, reflecting operational consistency and sector stability within the S&P 500 fund.
Merck (NYSE:MRK) S&P 500 Chart Mirrors Biotech Expansion
November 03, 2025 12:00 AM PST| By Team Kalkine MediaMerck & Co., Inc. (NYSE:MRK) strengthens its healthcare innovation through global research and diverse operations, reflecting scientific leadership and resilience shown across the S&P 500 Chart.
Stevanato Group (NYSE:STVN) Innovates Global Healthcare Design
November 03, 2025 12:00 AM PST| By Anmol KhazanchiStevanato Group S.p.A. (NYSE:STVN) enhances global healthcare through innovative packaging, containment, and automation systems, supporting the biopharma industry with precision and advanced engineering.
Cigna Group (NYSE:CI) Strengthens Integrated Care Model
October 31, 2025 12:00 AM PDT| By Anmol KhazanchiCigna Group (NYSE:CI) delivers global healthcare solutions through advanced technology, coordinated care, and wellness-focused services, reinforcing its leadership in medical, pharmaceutical, and behavioral health.
S&P Futures Strength Rise With Humana (NYSE:HUM) Operations
October 31, 2025 12:00 AM PDT| By Anmol KhazanchiHumana Inc. (NYSE:HUM) supports S&P futures through its integrated healthcare network, financial discipline, and technology-driven service framework, reflecting consistent stability in the U.S. health sector.
s&p 500 Trends Rise With Cardinal Health (NYSE:CAH) Expansion
October 31, 2025 12:00 AM PDT| By Anmol KhazanchiCardinal Health (NYSE:CAH) supports the S&P 500 through global healthcare distribution, advanced logistics, and sustainability initiatives that enhance operational efficiency and resilience across medical networks.
PTC Therapeutics (NASDAQ:PTCT) NASDAQ Composite Leads Biotech
October 31, 2025 12:00 AM PDT| By Anmol KhazanchiPTC Therapeutics (NASDAQ:PTCT) drives rare disease research and global biopharma innovation, aligning with technological and healthcare trends defining the Nasdaq Composite’s focus on scientific advancement.
S&P 500 Index Tracks Pfizer Inc. (NYSE:PFE) Health Leadership
October 30, 2025 12:00 AM PDT| By Anmol KhazanchiPfizer Inc. (NYSE:PFE) reinforces its leadership through vaccine innovation, global healthcare initiatives, and diversified therapeutics, mirroring the resilience and growth of major firms in the S&P 500 Index.
UnitedHealth Group Drops Amid Dow Jones Industrial Average Shift
October 29, 2025 04:45 PM PDT| By Anmol KhazanchiUnitedHealth Group (NYSE:UNH) faces a market decline, impacting Healthcare Stocks and the dow jones industrial index. Trading patterns and operational activities highlight sector trends and index movements.
Prime Medicine Update Reveals Latest Trends in Healthcare Stocks
October 29, 2025 04:15 PM PDT| By Anmol KhazanchiPrime Medicine (NYSE:PRME) drives innovation in Healthcare Stocks with its gene editing technology, strong market presence, institutional engagement, and research initiatives, highlighting its impact on the biotechnology sector.
Edwards Lifesciences (NYSE:EW) Market Activity and S&P 500 Futures
October 29, 2025 03:24 PM PDT| By Anmol KhazanchiEdwards Lifesciences (NYSE:EW) advances structural heart disease solutions, maintains strong market activity, and drives trends in the S&P 500 index, supported by global presence, technological innovation, and institutional participation.
